AKT1 and digestive system neoplasm: PGRN is known to promote proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways in other gastrointestinal tumors [8], and further investigation is needed to discover the role of PGRN as a biomarker and therapeutic target in GISTs.